Article Type
Changed
Fri, 01/18/2019 - 18:10

 

 

The 2018 annual meeting of the American Society of Hematology n San Diego included research presentations on more than 3,000 abstracts. In this special meetings edition of the MDedge Daily News we hear from Dr. Arok Khorana of the Cleveland Clinic on rivaroxaban for the prevention of VTE in cancer patients. We also hear from Dr. Ify Osunkwo of the Levine Cancer Institute on recent advances in sickle cell disease.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Topics
Sections

 

 

The 2018 annual meeting of the American Society of Hematology n San Diego included research presentations on more than 3,000 abstracts. In this special meetings edition of the MDedge Daily News we hear from Dr. Arok Khorana of the Cleveland Clinic on rivaroxaban for the prevention of VTE in cancer patients. We also hear from Dr. Ify Osunkwo of the Levine Cancer Institute on recent advances in sickle cell disease.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

 

 

The 2018 annual meeting of the American Society of Hematology n San Diego included research presentations on more than 3,000 abstracts. In this special meetings edition of the MDedge Daily News we hear from Dr. Arok Khorana of the Cleveland Clinic on rivaroxaban for the prevention of VTE in cancer patients. We also hear from Dr. Ify Osunkwo of the Levine Cancer Institute on recent advances in sickle cell disease.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica